Structure

Physi-Chem Properties

Molecular Weight:  502.98
Volume:  372.516
LogP:  1.181
LogD:  0.952
LogS:  -3.021
# Rotatable Bonds:  7
TPSA:  135.58
# H-Bond Aceptor:  9
# H-Bond Donor:  5
# Rings:  3
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.373
Synthetic Accessibility Score:  5.004
Fsp3:  0.438
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.538
MDCK Permeability:  4.241636270307936e-05
Pgp-inhibitor:  0.9
Pgp-substrate:  0.014
Human Intestinal Absorption (HIA):  0.918
20% Bioavailability (F20%):  0.995
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.581
Plasma Protein Binding (PPB):  86.7668228149414%
Volume Distribution (VD):  1.003
Pgp-substrate:  25.248645782470703%

ADMET: Metabolism

CYP1A2-inhibitor:  0.093
CYP1A2-substrate:  0.864
CYP2C19-inhibitor:  0.539
CYP2C19-substrate:  0.042
CYP2C9-inhibitor:  0.102
CYP2C9-substrate:  0.02
CYP2D6-inhibitor:  0.081
CYP2D6-substrate:  0.076
CYP3A4-inhibitor:  0.796
CYP3A4-substrate:  0.194

ADMET: Excretion

Clearance (CL):  1.377
Half-life (T1/2):  0.722

ADMET: Toxicity

hERG Blockers:  0.629
Human Hepatotoxicity (H-HT):  0.996
Drug-inuced Liver Injury (DILI):  0.929
AMES Toxicity:  0.905
Rat Oral Acute Toxicity:  0.945
Maximum Recommended Daily Dose:  0.901
Skin Sensitization:  0.931
Carcinogencity:  0.766
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.969

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC181086

Natural Product ID:  NPC181086
Common Name*:   Aerophobin 2
IUPAC Name:   (5S,6R)-N-[3-(2-amino-1H-imidazol-5-yl)propyl]-7,9-dibromo-6-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-2,7,9-triene-3-carboxamide
Synonyms:   Aerophobin 2
Standard InCHIKey:  ZSZRBAQVYFYMTR-XJKSGUPXSA-N
Standard InCHI:  InChI=1S/C16H19Br2N5O4/c1-26-12-9(17)5-16(13(24)11(12)18)6-10(23-27-16)14(25)20-4-2-3-8-7-21-15(19)22-8/h5,7,13,24H,2-4,6H2,1H3,(H,20,25)(H3,19,21,22)/t13-,16+/m0/s1
SMILES:  COC1=C(Br)[C@@H]([C@]2(C=C1Br)ON=C(C2)C(=O)NCCCc1c[nH]c(=N)[nH]1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL518701
PubChem CID:   159038
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000436] Azoles
        • [CHEMONTID:0000078] Imidazoles
          • [CHEMONTID:0002310] Substituted imidazoles
            • [CHEMONTID:0001225] Aminoimidazoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33394 druinella sp. Species n.a. n.a. n.a. Fujian, China n.a. PMID[12502317]
NPO40305 Pseudoceratina verrucosa Species Pseudoceratinidae Eukaryota n.a. n.a. n.a. PMID[23489291]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens ID50 > 10.0 ug ml-1 PMID[454375]
NPT111 Cell Line K562 Homo sapiens ID50 = 6.91 ug ml-1 PMID[454375]
NPT1523 Cell Line NFF Homo sapiens Inhibition = 25.0 % PMID[454376]
NPT306 Cell Line PC-3 Homo sapiens Inhibition = 66.0 % PMID[454376]
NPT165 Cell Line HeLa Homo sapiens Inhibition = 20.0 % PMID[454376]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC181086 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9844 High Similarity NPC81079
0.9843 High Similarity NPC304257
0.9286 High Similarity NPC260270
0.9206 High Similarity NPC145149
0.8692 High Similarity NPC1702
0.8692 High Similarity NPC158672
0.8496 Intermediate Similarity NPC477220
0.8385 Intermediate Similarity NPC66855
0.8273 Intermediate Similarity NPC289324
0.8258 Intermediate Similarity NPC313173
0.7958 Intermediate Similarity NPC300912
0.7958 Intermediate Similarity NPC202166
0.7958 Intermediate Similarity NPC473261
0.7958 Intermediate Similarity NPC473262
0.7902 Intermediate Similarity NPC470886
0.7635 Intermediate Similarity NPC130714
0.7552 Intermediate Similarity NPC473683
0.7324 Intermediate Similarity NPC172626
0.7324 Intermediate Similarity NPC470892
0.711 Intermediate Similarity NPC201900
0.6718 Remote Similarity NPC45830
0.6718 Remote Similarity NPC243106
0.6196 Remote Similarity NPC202866
0.6077 Remote Similarity NPC77435
0.6077 Remote Similarity NPC259071
0.6044 Remote Similarity NPC174607
0.6011 Remote Similarity NPC147847
0.5882 Remote Similarity NPC227953
0.5878 Remote Similarity NPC471261
0.5833 Remote Similarity NPC147238
0.5759 Remote Similarity NPC471256
0.5723 Remote Similarity NPC477400
0.5714 Remote Similarity NPC475610
0.5714 Remote Similarity NPC473249
0.5671 Remote Similarity NPC142761
0.5622 Remote Similarity NPC477254

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC181086 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5762 Remote Similarity NPD7623 Phase 3
0.5762 Remote Similarity NPD7624 Clinical (unspecified phase)
0.5714 Remote Similarity NPD7746 Phase 1
0.5714 Remote Similarity NPD7747 Phase 1
0.5625 Remote Similarity NPD8065 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data